Cryptosporidium parvum biliary tract infection in adult immunocompetent and immunosuppressed mice

Journal of Medical Microbiology

Volumn 47, Issue 1, 1998, Pages 71-77

  Verdon, R ^a,b   Polianski, Juliette ^a,b   Grodet, A ^b   Garry, L ^b   Carbon, C ^b  

^a CHU CÔTE DE NACRE   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY TRACT INFECTION; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INTESTINE INFECTION; MOUSE; NONHUMAN; PARASITISM; PRIORITY JOURNAL; SEROLOGY;

EID: 0031974458     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-1-71     Document Type: Article

References (17)

1. Current WL, Garcia LS. Cryptosporidiosis. Clin Microbiol Rev 1991; 4: 325-358.
2. Benhamou Y, Caumes E, Gerosa Y et al. AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients. Dig Dis Sci 1993; 38: 1113-1118.
3. Forbes A, Blanshard C, Gazzard B. Natural history of AIDS related sclerosing cholangitis: a study of 20 cases. Gut 1993; 34: 116-121.
4. Cello JP. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 1989; 86: 539-546.
5. Vakil NB, Schwartz SM, Buggy BP et al. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996; 334: 19-23.
6. Ungar BLP, Burris JA, Quinn CA, Finkelman FD. New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect Immun 1990; 58: 961-969.
7. Mead JR, Arrowood MJ, Sidwell RW, Healey MC. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Inject Dis 1991; 163: 1297-1304.
8. Brasseur P, Lemeteil D, Ballet J-J. Curative and preventive anticryptosporidium activities of sinefungin in an immunosuppressed adult rat model. Antimicrob Agents Chemother 1993; 37: 889-892.
9. Mead JR, Ilksoy N, You X et al. Infection dynamics and clinical features of cryptosporidiosis in SCID mice. Infect Immun 1994; 62: 1691-1695.
10. Regh JE. A comparison of anticryptosporidial activity of halofuginone with that of other aminoglycosides and azithromycin in immunosuppressed rats. J Antimicrob Chemother 1994; 170: 934-938.
11. Tzipori ST, Rand W, Theodos C. Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum. J Infect Dis 1995; 172: 1160-1164.
12. Ungar BLP, Soave R, Fayer R, Nash TE. Enzyme immunoassay of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons. J Infect Dis 1986; 153: 570-578.
13. Chrisp CE, Reid WC, Rush HG, Suckow MA, Bush A, Thomann MJ. Cryptosporidiosis in guinea pigs: an animal model. Infect Immun 1990; 58: 674-679.
14. Johansen GA, Sterling CR. Detection of a prolonged C, parvum infection in immunocompetent adult C57BL/6 mice. J Eukaryot Microbiol 1994; 41: 45S.
15. Campbell AT, Robertson LJ, Smith HV. Viability of Cryptosporidium parvum oocysts: correlation of in vitro excystation with inclusion of fluorogenic vital dyes. Appl Environ Microbiol 1992; 58: Suppl: 3488-3493.
16. Gut J, Petersen C, Nelson R, Leech J. Cryptosporidium parvum: in vitro cultivation in Madin-Darby canine kidney cells. J Protozool 1991; 38: 72S-73S.
17. Rasmussen KR, Healey MC. Experimental Cryptosporidium parvum infections in immunosuppressed adult mice. Infect Immun 1992; 60: 1648-1652.